Avalon GloboCare Corp (AVCO)

Etorro trading 970x250
Avalon GloboCare Corp (AVCO) Logo

About Avalon GloboCare Corp

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People’s Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. It also develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology. In addition, the company develops proprietary diagnostic and therapeutic products leveraging exosome technology; and provides development services for hospitals. The company has a strategic partnership with Weill Cornell Medical College to co-develop bio-production and standardization procedures for chimeric antigen receptor (CAR)-T Therapy; GensKey Medical Technology Co. Ltd. to co-develop and commercialize point-of-care, rapid detection antibody tests to identify whether a patient has been exposed to and has developed antibodies against SARS-CoV-2; GE Healthcare to enhance standardized automation and bio-production for cellular medicines; and HydroPeptide, LLC to co-develop and commercialize various clinical-grade, exosome-based cosmeceutical and orthopedic products, as well as research agreement with Massachusetts Institute of Technology to develop CAR technology. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey. Address: 4400 Route 9 South, Freehold, NJ, United States, 07728

Avalon GloboCare Corp News and around…

Latest news about Avalon GloboCare Corp (AVCO) common stock and company :

Avalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular Immunotherapy
14 Oct, 2021 Yahoo! Finance

Co-developed novel technology platform combining S-layer proteins and emulsomes for diverse applications in bio-delivery of drugs and genes with the University of Natural Resources and Life Sciences (BOKU) Vienna FREEHOLD, N.J., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced it has successfully co-developed a novel platform of S-layer coated emulsome te

This NASDAQ has Life Saving Advances in Today’s Most Critical Bio-Science Fields of Cancer & Immune Related Disease, Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
13 Oct, 2021 FinancialContent
This NASDAQ has Life Saving Advances in Today's Most Critical Bio-Science Fields of Cancer and Immune Related Disease, Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
13 Oct, 2021 FinancialContent
12 Health Care Stocks Moving In Thursday's After-Market Session
07 Oct, 2021 FinancialContent

Gainers Vaxart (NASDAQ:VXRT) shares increased by 12.27% to $7.96 during Thursday's after-market session. This security traded at a ...

Avalon GloboCare's Advanced Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
07 Oct, 2021 FinancialContent

Image Provided by Pixabay Cytokine storm has made frequent appearances in the news lately as a life-threatening complication in ...

Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related Diseases
07 Oct, 2021 Yahoo! Finance

Avalon and research partner, University of Natural Resources and Life Sciences (BOKU), in Vienna, Austria, co-develop a novel technology to efficiently synthesize and study previously difficult to work with drug targets Technology will facilitate drug design for cancer and immune-related diseasesStudy describing the new cell-free, in-silico technology published in September 2021 issue of peer-reviewed journal Membranes FREEHOLD, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NAS

Avalon GloboCare Aims to Revolutionize Cell Therapy Market with a Faster, Safer CAR-T Treatment
30 Sep, 2021 FinancialContent

Image Provided by Pexels With a compound annual growth rate (CAGR) of 34.2%, the global CAR-T cell therapy market is projected to hit ...

Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients
29 Sep, 2021 FinancialContent

Battling cancer is often a long journey—and one that becomes even more challenging for the large number of patients who find that ...

Avalon GloboCare to Present at the Benzinga Healthcare Small Cap Conference on September 30th
23 Sep, 2021 FinancialContent
Sysorex Elects Nasdaq-Listed Company CEO William Stilley to Board of Directors
13 Sep, 2021 FinancialContent
INVESTIGATION: Halper Sadeh LLP Investigates INOV, SAFM, LMRK, AVCO, TRIL, XENT; Shareholders are Encouraged to Contact the Firm
09 Sep, 2021 Yahoo! Finance

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

AVALON GLOBOCARE INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Avalon GloboCare Corp. - AVCO
08 Sep, 2021 FinancialContent

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Hebei Senlang Biotechnology Co. Ltd. to Avalon GloboCare Corp. (“the Company”) (NasdaqCM: AVCO). Under the terms of the proposed transaction, Avalon will reportedly issue 81 million shares of its common stock to acquire SenlangBio. KSF is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company’s shareholders.

12 Health Care Stocks Moving In Wednesday's After-Market Session
01 Sep, 2021 FinancialContent

Gainers INmune Bio (NASDAQ:INMB) shares moved upwards by 18.76% to $28.35 during Wednesday's after-market session. Trading volume ...

12 Health Care Stocks Moving In Monday's Intraday Session
23 Aug, 2021 FinancialContent

Gainers Vivos Therapeutics (NASDAQ:VVOS) stock rose 45.44% to $5.58 during Monday's regular session. As of 12:30 ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
18 Aug, 2021 FinancialContent

Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 119.0% to $7.49 during Wednesday's regular session. Trading ...

UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCare
04 Aug, 2021 FinancialContent
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates KRG, ALTA, AVCO, ICBK; Shareholders are Encouraged to Contact the Firm
20 Jul, 2021 FinancialContent
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Avalon GloboCare Corp. Merger
19 Jul, 2021 FinancialContent
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Avalon GloboCare Corp. Merger
19 Jul, 2021 Yahoo! Finance

WILMINGTON, Del., July 19, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Avalon GloboCare Corp. (“Avalon”) (NASDAQ GS: AVCO) regarding possible breaches of fiduciary duties and other violations of law related to Avalon’s agreement to merge with Lonlon Biotech Ltd. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-avalon-globocare-corp. You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CAI, SYKE, TGRF, AVCO, LDL; Shareholders are Encouraged to Contact the Firm
18 Jul, 2021 Yahoo! Finance

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Avalon GloboCare Corp. - AVCO
17 Jul, 2021 Yahoo! Finance

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Avalon GloboCare Corp. ("AVCO" or the "Company") (AVCO) relating to its proposed merger with Hebei Senlang Biotechnology Co. Ltd.

Proactive news headlines including AEX Gold, Helix BioPharma, Imagine AR, Empower Clinics and Kintara Therapeutics
01 Jul, 2021 FinancialContent
Avalon GloboCare Announces its Planned Acquisition Target, SenlangBio, has Initiated First-In-Human Clinical Trial in Recurrent Brain Cancer
01 Jul, 2021 FinancialContent
Proactive news headlines including The Parent Company, Phunware, Plurilock Security and Hannan Metals
28 Jun, 2021 FinancialContent
Avalon GloboCare CEO Provides Letter to Update Shareholders About Acquisition of SenlangBio
28 Jun, 2021 FinancialContent
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, MDP, FMBI, AVCO; Shareholders are Encouraged to Contact the Firm
21 Jun, 2021 FinancialContent
Lifshitz Law Firm, P.C. Announces Investigation of AVCO, ICON, KIN, and KNL
18 Jun, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / June 18, 2021 / Lifshitz Law Firm, P. (NASDAQ:AVCO)Lifshitz Law Firm, P.

INVESTIGATION ALERT: Halper Sadeh LLP Investigates FBNC, AVCO, XEC, CLDR, SBBP; Shareholders are Encouraged to Contact the Firm
16 Jun, 2021 Yahoo! Finance

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Lifshitz Law Firm, P.C. Announces Investigation of ALTA, AVCO, CORE, and EBSB
15 Jun, 2021 FinancialContent
Avalon Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Avalon GloboCare Corp. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – AVCO
14 Jun, 2021 FinancialContent

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Avalon GloboCare Corp. (NASDAQ: AVCO) and Hebei Senlang Biotechnology Co. Ltd is fair to Avalon shareholders. In connection with the transaction, Avalon will issue 81 million shares of its common stock to acquire SenlangBio.

Avalon GloboCare Corp (AVCO) is a NASDAQ Common Stock listed in , ,

970x250